These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 20378689)
1. PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541. Hägerstrand D; Lindh MB; Peña C; Garcia-Echeverria C; Nistér M; Hofmann F; Ostman A Neuro Oncol; 2010 Sep; 12(9):967-75. PubMed ID: 20378689 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells. Isebaert SF; Swinnen JV; McBride WH; Haustermans KM Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290 [TBL] [Abstract][Full Text] [Related]
3. Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research Award. Whitson BA; Jacobson BA; Frizelle S; Patel MR; Yee D; Maddaus MA; Kratzke RA Ann Thorac Surg; 2006 Sep; 82(3):996-1001; discussion 1001-2. PubMed ID: 16928523 [TBL] [Abstract][Full Text] [Related]
4. Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance. Wolf S; Lorenz J; Mössner J; Wiedmann M World J Gastroenterol; 2010 Jan; 16(2):156-66. PubMed ID: 20066734 [TBL] [Abstract][Full Text] [Related]
5. Esophageal cancer exhibits resistance to a novel IGF-1R inhibitor NVP-AEW541 with maintained RAS-MAPK activity. Bao XH; Takaoka M; Hao HF; Wang ZG; Fukazawa T; Yamatsuji T; Sakurama K; Sun DS; Nagasaka T; Fujiwara T; Naomoto Y Anticancer Res; 2012 Jul; 32(7):2827-34. PubMed ID: 22753744 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo. Tanno B; Mancini C; Vitali R; Mancuso M; McDowell HP; Dominici C; Raschellà G Clin Cancer Res; 2006 Nov; 12(22):6772-80. PubMed ID: 17121898 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38. Gohr K; Hamacher A; Engelke LH; Kassack MU BMC Cancer; 2017 Nov; 17(1):711. PubMed ID: 29100507 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase B modulates the sensitivity of human neuroblastoma cells to insulin-like growth factor receptor inhibition. Guerreiro AS; Boller D; Shalaby T; Grotzer MA; Arcaro A Int J Cancer; 2006 Dec; 119(11):2527-38. PubMed ID: 16988940 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas. Piao W; Wang Y; Adachi Y; Yamamoto H; Li R; Imsumran A; Li H; Maehata T; Ii M; Arimura Y; Lee CT; Shinomura Y; Carbone DP; Imai K Mol Cancer Ther; 2008 Jun; 7(6):1483-93. PubMed ID: 18566219 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of acquired resistance to insulin-like growth factor 1 receptor inhibitor in MCF-7 breast cancer cell line. Ekyalongo RC; Mukohara T; Kataoka Y; Funakoshi Y; Tomioka H; Kiyota N; Fujiwara Y; Minami H Invest New Drugs; 2013 Apr; 31(2):293-303. PubMed ID: 22828916 [TBL] [Abstract][Full Text] [Related]
12. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy. Warshamana-Greene GS; Litz J; Buchdunger E; García-Echeverría C; Hofmann F; Krystal GW Clin Cancer Res; 2005 Feb; 11(4):1563-71. PubMed ID: 15746061 [TBL] [Abstract][Full Text] [Related]
13. Co-administration of NVP-AEW541 and dasatinib induces mitochondrial-mediated apoptosis through Bax activation in malignant human glioma cell lines. Premkumar DR; Jane EP; Pollack IF Int J Oncol; 2010 Sep; 37(3):633-43. PubMed ID: 20664932 [TBL] [Abstract][Full Text] [Related]
15. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells. Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375 [TBL] [Abstract][Full Text] [Related]
16. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells. Höpfner M; Huether A; Sutter AP; Baradari V; Schuppan D; Scherübl H Biochem Pharmacol; 2006 May; 71(10):1435-48. PubMed ID: 16530734 [TBL] [Abstract][Full Text] [Related]
17. Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells. Wu W; Ma J; Shao N; Shi Y; Liu R; Li W; Lin Y; Wang S PLoS One; 2017; 12(1):e0169229. PubMed ID: 28046018 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis. Moser C; Schachtschneider P; Lang SA; Gaumann A; Mori A; Zimmermann J; Schlitt HJ; Geissler EK; Stoeltzing O Eur J Cancer; 2008 Jul; 44(11):1577-86. PubMed ID: 18445520 [TBL] [Abstract][Full Text] [Related]
19. The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells. Maiso P; Ocio EM; Garayoa M; Montero JC; Hofmann F; García-Echeverría C; Zimmermann J; Pandiella A; San Miguel JF Br J Haematol; 2008 May; 141(4):470-82. PubMed ID: 18341634 [TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours. Höpfner M; Baradari V; Huether A; Schöfl C; Scherübl H Endocr Relat Cancer; 2006 Mar; 13(1):135-49. PubMed ID: 16601284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]